181 related articles for article (PubMed ID: 24761916)
1. Situation of HPV16 E2 gene status during radiotherapy treatment of cervical carcinoma.
Kahla S; Kochbati L; Maalej M; Oueslati R
Asian Pac J Cancer Prev; 2014; 15(6):2869-73. PubMed ID: 24761916
[TBL] [Abstract][Full Text] [Related]
2. HPV16 E2 variants correlated with radiotherapy treatment and biological significance in cervical cell carcinoma.
Kahla S; Hammami S; Kochbati L; Chanoufi MB; Oueslati R
Infect Genet Evol; 2018 Nov; 65():238-243. PubMed ID: 30081093
[TBL] [Abstract][Full Text] [Related]
3. Methylation at 3'LCR of HPV16 can be affected by patient age and disruption of E1 or E2 genes.
Filho SMA; Bertoni N; Brant AC; Vidal JPCB; Felix SP; Cavalcanti SMB; Carestiato FN; Martins LFL; Almeida LM; Moreira MAM
Virus Res; 2017 Mar; 232():48-53. PubMed ID: 28143725
[TBL] [Abstract][Full Text] [Related]
4. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
[TBL] [Abstract][Full Text] [Related]
5. Impact of viral E2-gene status on outcome after radiotherapy for patients with human papillomavirus 16-positive cancer of the uterine cervix.
Lindel K; de Villiers EM; Burri P; Studer U; Altermatt HJ; Greiner RH; Gruber G
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):760-5. PubMed ID: 16682151
[TBL] [Abstract][Full Text] [Related]
6. Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome.
Cheung JL; Cheung TH; Yu MY; Chan PK
Gynecol Oncol; 2013 Nov; 131(2):374-9. PubMed ID: 24012799
[TBL] [Abstract][Full Text] [Related]
7. Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16.
Hong D; Liu J; Hu Y; Lu X; Li B; Li Y; Hu D; Lu W; Xie X; Cheng X
BMC Cancer; 2017 Feb; 17(1):136. PubMed ID: 28202002
[TBL] [Abstract][Full Text] [Related]
8. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.
Cricca M; Morselli-Labate AM; Venturoli S; Ambretti S; Gentilomi GA; Gallinella G; Costa S; Musiani M; Zerbini M
Gynecol Oncol; 2007 Sep; 106(3):549-57. PubMed ID: 17568661
[TBL] [Abstract][Full Text] [Related]
9. HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer.
Amaro-Filho SM; Pereira Chaves CB; Felix SP; Basto DL; de Almeida LM; Moreira MAM
Papillomavirus Res; 2018 Jun; 5():172-179. PubMed ID: 29649654
[TBL] [Abstract][Full Text] [Related]
10. Methylation of p16 ink4a promoter is independent of human papillomavirus DNA physical state: a comparison between cervical pre-neoplastic and neoplastic samples.
Carestiato FN; Amaro-Filho SM; Moreira MAM; Cavalcanti SMB
Mem Inst Oswaldo Cruz; 2018 Dec; 114():e180456. PubMed ID: 30569945
[TBL] [Abstract][Full Text] [Related]
11. [Analysis on the expression of human papillomavirus type 16 E2 and E6 oncogenes and disruption of E2 in cervical cancer].
Wang JT; Ding L; Gao ES; Cheng YY
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):968-71. PubMed ID: 18399141
[TBL] [Abstract][Full Text] [Related]
12. The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma.
Li W; Wang W; Si M; Han L; Gao Q; Luo A; Li Y; Lu Y; Wang S; Ma D
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1355-61. PubMed ID: 18478264
[TBL] [Abstract][Full Text] [Related]
13. Analysis of E2 gene integrity in HPV16 and HPV58 viruses isolated from women with cervical pathology.
González-Losa MD; Puerto-Solis M; Tenorio Ruiz J; Rosado-López AI; Hau-Aviles O; Ayora-Talavera G; Cisneros-Cutz I; Conde-Ferráez L
Mem Inst Oswaldo Cruz; 2016 Dec; 111(12):770-773. PubMed ID: 27812600
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting?
Boulet GA; Benoy IH; Depuydt CE; Horvath CA; Aerts M; Hens N; Vereecken AJ; Bogers JJ
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2992-9. PubMed ID: 19861526
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology.
Liu Y; Lu Z; Xu R; Ke Y
Oncotarget; 2016 Feb; 7(5):5852-64. PubMed ID: 26735580
[TBL] [Abstract][Full Text] [Related]
16. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
Zheng Y; Peng ZL; Lou JY; Wang H
Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms and functional analysis of the intact human papillomavirus16 e2 gene.
Ekalaksananan T; Jungpol W; Prasitthimay C; Wongjampa W; Kongyingyoes B; Pientong C
Asian Pac J Cancer Prev; 2014; 15(23):10255-62. PubMed ID: 25556457
[TBL] [Abstract][Full Text] [Related]
18. The relationship between c-FLIP expression and human papillomavirus E2 gene disruption in cervical carcinogenesis.
Wang W; Wang S; Song X; Sima N; Xu X; Luo A; Chen G; Deng D; Xu Q; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Jun; 105(3):571-7. PubMed ID: 17433827
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of the integration status for human papillomavirus 16 in esophageal carcinoma samples.
Li S; Shen H; Li J; Hou X; Zhang K; Li J
Turk J Gastroenterol; 2018 Mar; 29(2):157-163. PubMed ID: 29749321
[TBL] [Abstract][Full Text] [Related]
20. Critical evaluation of HPV16 gene copy number quantification by SYBR green PCR.
Roberts I; Ng G; Foster N; Stanley M; Herdman MT; Pett MR; Teschendorff A; Coleman N
BMC Biotechnol; 2008 Jul; 8():57. PubMed ID: 18652663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]